AU2001247782A1 - 18221, dual specificity phosphatase and uses thereof - Google Patents

18221, dual specificity phosphatase and uses thereof

Info

Publication number
AU2001247782A1
AU2001247782A1 AU2001247782A AU4778201A AU2001247782A1 AU 2001247782 A1 AU2001247782 A1 AU 2001247782A1 AU 2001247782 A AU2001247782 A AU 2001247782A AU 4778201 A AU4778201 A AU 4778201A AU 2001247782 A1 AU2001247782 A1 AU 2001247782A1
Authority
AU
Australia
Prior art keywords
dual specificity
specificity phosphatase
phosphatase
dual
specificity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247782A
Inventor
Rachel E Meyers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001247782A1 publication Critical patent/AU2001247782A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001247782A 2000-03-24 2001-03-22 18221, dual specificity phosphatase and uses thereof Abandoned AU2001247782A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19185800P 2000-03-24 2000-03-24
US60/191,858 2000-03-24
PCT/US2001/009603 WO2001073060A2 (en) 2000-03-24 2001-03-22 18221, dual specificity phosphatase and uses thereof

Publications (1)

Publication Number Publication Date
AU2001247782A1 true AU2001247782A1 (en) 2001-10-08

Family

ID=22707181

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001247782A Abandoned AU2001247782A1 (en) 2000-03-24 2001-03-22 18221, dual specificity phosphatase and uses thereof
AU2001249423A Abandoned AU2001249423A1 (en) 2000-03-24 2001-03-23 38692 and 21117, novel dual specificity phosphatase molecules and uses therefor

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001249423A Abandoned AU2001249423A1 (en) 2000-03-24 2001-03-23 38692 and 21117, novel dual specificity phosphatase molecules and uses therefor

Country Status (4)

Country Link
US (2) US20020065406A1 (en)
EP (2) EP1268818A2 (en)
AU (2) AU2001247782A1 (en)
WO (2) WO2001073060A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479270B1 (en) * 2000-02-14 2002-11-12 Pe Corporation (Ny) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
US20020137170A1 (en) * 2000-09-26 2002-09-26 Ceptyr, Inc. DSP-16 dual-specificity phosphatase
DE10056802B4 (en) * 2000-11-14 2005-06-16 Epigenomics Ag Method for the detection of methylation conditions for toxicological diagnostics
WO2002057460A2 (en) * 2000-12-20 2002-07-25 Bristol-Myers Squibb Company Polynucleotides encoding human phosphatases
AU2003271656A1 (en) * 2002-09-27 2004-04-19 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Skrp, astray, string, vacm associated with metabolic control
US7834250B2 (en) 2004-04-22 2010-11-16 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
CN102559364B (en) 2004-04-22 2016-08-17 联邦科学技术研究组织 Use recombinant cell synthesis of long-chain polyunsaturated fatty acids
EP1771563A2 (en) 2004-05-28 2007-04-11 Ambion, Inc. METHODS AND COMPOSITIONS INVOLVING MicroRNA
ES2534304T3 (en) 2004-11-12 2015-04-21 Asuragen, Inc. Procedures and compositions involving miRNA and miRNA inhibitor molecules
CA2661697A1 (en) 2006-08-29 2008-03-06 Commonwealth Scientific And Industrial Research Organisation Synthesis of fatty acids
EP2487240B1 (en) * 2006-09-19 2016-11-16 Interpace Diagnostics, LLC Micrornas differentially expressed in pancreatic diseases and uses thereof
CA2663962A1 (en) * 2006-09-19 2008-03-27 Asuragen, Inc. Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
US20090092974A1 (en) * 2006-12-08 2009-04-09 Asuragen, Inc. Micrornas differentially expressed in leukemia and uses thereof
EP2104735A2 (en) * 2006-12-08 2009-09-30 Asuragen, INC. Mir-21 regulated genes and pathways as targets for therapeutic intervention
CA2671299A1 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Functions and targets of let-7 micro rnas
US20090175827A1 (en) * 2006-12-29 2009-07-09 Byrom Mike W miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090131354A1 (en) * 2007-05-22 2009-05-21 Bader Andreas G miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090232893A1 (en) * 2007-05-22 2009-09-17 Bader Andreas G miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
CA2689974A1 (en) * 2007-06-08 2008-12-18 Asuragen, Inc. Mir-34 regulated genes and pathways as targets for therapeutic intervention
WO2009036332A1 (en) 2007-09-14 2009-03-19 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
US20090186015A1 (en) * 2007-10-18 2009-07-23 Latham Gary J Micrornas differentially expressed in lung diseases and uses thereof
WO2009070805A2 (en) * 2007-12-01 2009-06-04 Asuragen, Inc. Mir-124 regulated genes and pathways as targets for therapeutic intervention
WO2009086156A2 (en) * 2007-12-21 2009-07-09 Asuragen, Inc. Mir-10 regulated genes and pathways as targets for therapeutic intervention
EP2260110B1 (en) * 2008-02-08 2014-11-12 Asuragen, INC. miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
WO2009111643A2 (en) * 2008-03-06 2009-09-11 Asuragen, Inc. Microrna markers for recurrence of colorectal cancer
EP2271757A2 (en) * 2008-03-26 2011-01-12 Asuragen, INC. Compositions and methods related to mir-16 and therapy of prostate cancer
EP2990487A1 (en) 2008-05-08 2016-03-02 Asuragen, INC. Compositions and methods related to mirna modulation of neovascularization or angiogenesis
WO2010056737A2 (en) * 2008-11-11 2010-05-20 Mirna Therapeutics, Inc. Methods and compositions involving mirnas in cancer stem cells
EP2358882B1 (en) 2008-11-18 2017-07-26 Commonwealth Scientific and Industrial Research Organisation Enzymes and methods for producing omega-3 fatty acids
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
US8946460B2 (en) 2012-06-15 2015-02-03 Commonwealth Scientific And Industrial Research Organisation Process for producing polyunsaturated fatty acids in an esterified form
SG11201604871VA (en) 2013-12-18 2016-07-28 Commw Scient Ind Res Org Lipid comprising long chain polyunsaturated fatty acids
KR102527795B1 (en) 2014-06-27 2023-05-02 커먼웰쓰 사이언티픽 앤 인더스트리알 리서치 오거니제이션 Lipid comprising docosapentaenoic acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516059D0 (en) * 1995-08-04 1995-10-04 Medical Res Council Novel genes and proteins
AU8479498A (en) * 1997-07-08 1999-02-08 Cold Spring Harbor Laboratory Dual specificity phosphatase and methods of use
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
EP1171614A1 (en) * 1999-04-07 2002-01-16 Ceptyr, Inc. Dsp-4 dual-specificity map kinase phosphatase
EP1212433A2 (en) * 1999-08-13 2002-06-12 Sugen, Inc. Protein phosphatases and diagnosis and treatment of phosphatase-related disorders
AU7829700A (en) 1999-09-15 2001-04-17 Incyte Genomics, Inc. Protein phosphatase and kinase proteins
WO2001046394A2 (en) 1999-12-21 2001-06-28 Sugen, Inc. Mammalian protein phosphatases

Also Published As

Publication number Publication date
WO2001073060A9 (en) 2002-12-19
WO2001073059A3 (en) 2002-06-20
WO2001073060A3 (en) 2002-04-04
AU2001249423A1 (en) 2001-10-08
EP1319078A2 (en) 2003-06-18
US20020034807A1 (en) 2002-03-21
WO2001073060A2 (en) 2001-10-04
EP1268818A2 (en) 2003-01-02
WO2001073059A2 (en) 2001-10-04
US20020065406A1 (en) 2002-05-30
US6664089B2 (en) 2003-12-16

Similar Documents

Publication Publication Date Title
AU2001247782A1 (en) 18221, dual specificity phosphatase and uses thereof
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2001232761A1 (en) Fully-locking torque-proportioning differential
AU2002211717A1 (en) Stresscopins and their uses
AU2001292388A1 (en) Men's brief
AU2001280590A1 (en) 5-substituted 2-aryl-4-pyrimidinones
AU2002224876A1 (en) Isolated luciferases and the use thereof
AU2001232041A1 (en) Improved assay
AU2001232132A1 (en) Novel assay
AU2001237592A1 (en) Enzymes and uses relating thereto
AU2001245463A1 (en) 26583, a novel serine/threonine phosphatase and uses therefor
AU2001240793A1 (en) Novel assay
AU2001268264A1 (en) Resazurin-based cytotoxicity assay
AU5240901A (en) Assay
AU2001239897A1 (en) 18232, a dual specificity phosphatase
AU2002236595A1 (en) Enzymes
AU6390001A (en) 6,10-dimethyl-5,9-undecadien-2-ol
AU2001260045A1 (en) Secure pants
AU2002221623A1 (en) Gene 4
AU2001243380A1 (en) Anonymous id
AU3389501A (en) Assay
AU2001276499A1 (en) Assay
AU2001277689A1 (en) The easy-parker-indicator